Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-25 @ 1:47 PM
NCT ID: NCT01847092
Description: None
Frequency Threshold: 5
Time Frame: 12 Weeks
Study: NCT01847092
Study Brief: A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AZD1722 AZD1722 in 5, 15, 30, or 60 mg capsules. Starting dose is 15 mg BID PO for 12 Weeks AZD1722 0 None 3 77 45 77 View
Placebo Placebo capsule BID PO for 12 Weeks Placebo: Placebo for AZD1722 0 None 2 77 4 77 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hyperkalemia NON_SYSTEMATIC_ASSESSMENT Investigations None View
Deep Vein Thrombosis NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Cardiac failure congestive NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View